Back
Arcus Biosciences Quote, Financials, Valuation and Earnings
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.
Buy
56
RCUS
Arcus Biosciences
Last Price:
15.71
Seasonality Move:
8.7%
7 Day Trial
ALL ACCESS PASS
$
7
Trump wins! Dow to 75,000? Details here
See the explosive "Document 20" details here.Arcus Biosciences Price Quote
$15.71
+0.01 (+-0.38%)
(Updated: November 16, 2024 at 5:35 AM ET)
Arcus Biosciences Key Stats
Buy
56
Arcus Biosciences (RCUS)
is a Buy
Day range:
$14.90 - $16.05
52-week range:
$13.50 - $20.31
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
5.16
P/B ratio:
2.55%
Volume:
923.6K
Avg. volume:
867.3K
1-year change:
7.9%
Market cap:
$1.4B
Revenue:
$117M
EPS:
$-3.15
How Much Does Arcus Biosciences Make?
-
How Much Are Arcus Biosciences's Sales Annually?
RCUS Revenues are $117M -
How Much Profit Does Arcus Biosciences's Make A Year?
RCUS net income is -$307M
Is Arcus Biosciences Growing As A Company?
-
What Is Arcus Biosciences's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.5% -
What Is Arcus Biosciences's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Arcus Biosciences Stock Price Performance
-
Did Arcus Biosciences Stock Go Up Last Month?
Arcus Biosciences share price went down by -11.7% last month -
Did RCUS's Share Price Rise Over The Last Year?
RCUS share price rose by 7.9% over the past 1 year
What Is Arcus Biosciences 52-Week High & Low?
-
What Is Arcus Biosciences’s 52-Week High Share Price?
Arcus Biosciences has traded as high as $20.31 over the past 52 weeks -
What Is Arcus Biosciences’s 52-Week Low Share Price?
Arcus Biosciences has traded as low as $13.50 over the past 52 weeks
Arcus Biosciences Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Arcus Biosciences?
-
How Much Debt Does Arcus Biosciences Have?
Total long term debt quarterly is $47M -
How Much Cash Does Arcus Biosciences Have?
Cash and short term investments quarterly total is $1.1B -
What Is Arcus Biosciences’s Book Value Per Share?
Book value per share is 6.17
Is Arcus Biosciences Cash Flow Positive?
-
What Is RCUS Cash Flow From Operations?
Cash flow from operations (TTM) is -$158M -
What Is Arcus Biosciences’s Cash Flow From Financing?
Cash flow from financing (TTM) is $282M -
What Is Arcus Biosciences’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$107M
Arcus Biosciences Return On Invested Capital
-
Is Management Doing A Good Job?
RCUS return on invested capital is -45.98% -
What Is Arcus Biosciences Return On Assets?
ROA measures how assets are converting to revenues and is -22.44% -
What Is RCUS Return On Equity?
ROE is a measure of profitability and is -46.73%
Arcus Biosciences Earnings Date & Stock Price
-
What Is Arcus Biosciences's Stock Price Today?
A single share of RCUS can be purchased today for 15.70 -
What Is Arcus Biosciences’s Stock Symbol?
Arcus Biosciences trades on the nyse under the ticker symbol: RCUS -
When Is Arcus Biosciences’s Next Earnings Date?
The next quarterly earnings date for Arcus Biosciences is scheduled on February 21, 2025 -
When Is RCUS's next ex-dividend date?
Arcus Biosciences's next ex-dividend date is November 16, 2024 -
How To Buy Arcus Biosciences Stock?
You can buy Arcus Biosciences shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Arcus Biosciences Competitors
-
Who Are Arcus Biosciences's Competitors?
Below is a list of companies who compete with Arcus Biosciences or are related in some way:
Arcus Biosciences Dividend Yield
-
What Is RCUS Dividend Yield?
Arcus Biosciences’s dividend yield currently is 0% -
What Is Arcus Biosciences’s Payout Ratio?
Arcus Biosciences’s payout ratio is 0% -
When Did Arcus Biosciences Last Pay A Dividend?
The latest dividend pay date is November 16, 2024 -
What Is Arcus Biosciences’s Dividend Per Share?
Arcus Biosciences pays a dividend of $0.00 per share
Arcus Biosciences Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 6.32% |
| Revenue: | 50% | 23.23% |
Analyst Recommendations
| Buy Recommendations: | 8 |
|---|---|
| Hold Recommendations: | 3 |
| Sell Recommendations: | 0 |
| Price Target: | 33.20 |
| Upside from Last Price: | 111.46% |